设为首页 加入收藏

Ireland[爱尔兰药品]

Exforge 5 mg/80 mg film-coated tabletsValsartanAmlodipine be
TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadminis..
录入者:admin       发表于:2013-11-02            查阅全文...
Exforge HCT 5 mg/160 mg/25 mg film-coated tabletsHydrochloro
TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadministration ..
录入者:admin       发表于:2013-11-02            查阅全文...
Exforge HCT 10 mg/160 mg/12.5 mg film-coated tabletsHydrochl
TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadministration ..
录入者:admin       发表于:2013-11-02            查阅全文...
Cimzia 200 mg solution for injectionCertolizumab Pegol
TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadministration ..
录入者:admin       发表于:2013-11-01            查阅全文...
Remicade 100 mg powder for concentrate for solution for infu
TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadministration ..
录入者:admin       发表于:2013-11-01            查阅全文...
MEPACT 4 mg powder for suspension for infusion.Mifamurtide
TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadministration ..
录入者:admin       发表于:2013-10-30            查阅全文...
MabCampath 30 mg/ml concentrate for solution for infusionAle
TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadministration ..
录入者:admin       发表于:2013-10-30            查阅全文...
ZYTIGA 250 mg tabletsAbiraterone Acetate
TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadministration ..
录入者:admin       发表于:2013-10-29            查阅全文...
Tygacil 50 mg powder for solution for infusion.Tigecycline
TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadministration ..
录入者:admin       发表于:2013-10-27            查阅全文...
Alkeran 50mg, Powder and Solvent for Solution for InfusionMe
TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadministration ..
录入者:admin       发表于:2013-10-27            查阅全文...
Alkeran 2mg Film-coated TabletsMelphalan
TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadministration ..
录入者:admin       发表于:2013-10-27            查阅全文...
Alkeran 2mg Film-coated TabletsMelphalan
TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadministration ..
录入者:admin       发表于:2013-10-27            查阅全文...
Victrelis 200 mg hard capsules
TableofContents 1.Nameofthemedicinalproduct 2.Qualitativeandquantitativecomposition 3.Pharmaceuticalform 4.Clinicalparticulars 4.1Therapeuticindications 4.2Posologyandmethodofadminis..
录入者:admin       发表于:2013-10-24            查阅全文...
Xalatan 0.005% w/v eye drops solution.Latanoprost
TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadminis..
录入者:admin       发表于:2013-10-23            查阅全文...
Urorec 8 mg hard capsulesSilodosin
TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadminis..
录入者:admin       发表于:2013-10-12            查阅全文...
Urorec 4 mg hard capsulesSilodosin
TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadminis..
录入者:admin       发表于:2013-10-12            查阅全文...
Busilvex 6 mg/ml concentrate for solution for infusion
TableofContents 1.Nameofthemedicinalproduct 2.Qualitativeandquantitativecomposition 3.Pharmaceuticalform 4.Clinicalparticulars 4.1Therapeuticindications 4.2Posologyandmethodofadminis..
录入者:admin       发表于:2013-10-12            查阅全文...
ERBITUX*2MG/ML IV FL 50ML
NOMECOMMERCIALE ERBITUX*2MG/MLIVFL50ML AZIENDA MerckSeronoS.p.A. ..
录入者:admin       发表于:2013-10-10            查阅全文...
ERBITUX*5MG/ML IV FL 20ML
NOMECOMMERCIALE ERBITUX*5MG/MLIVFL20ML AZIENDA MerckSeronoS.p.A. ..
录入者:admin       发表于:2013-10-10            查阅全文...
Inlyta 1 mg 3mg, 5 mg & 7mg film-coated tablets
Thismedicinalproductissubjecttoadditionalmonitoring.Thiswillallowquickidentificationofnewsafetyinformation.Healthcareprofessionalsareaskedtoreportanysuspectedadversereactions.Seesection4.8forhow..
录入者:admin       发表于:2013-10-05            查阅全文...

相关栏目

热门文章

推荐文章

广告位